Castleman Disease Treatment Market Regional Analysis and Competitive Landscape
The Castleman disease treatment market exhibits distinct regional characteristics that reflect varying rare disease diagnostic capabilities, access to biologic therapies, healthcare infrastructure, and research expertise. North America retained market leadership with 41.2% of global share in 2025, underpinned by the United States' dominant position in rare disease drug development and access,...
0 Kommentare 0 Geteilt 2 Ansichten 0 Bewertungen